Iterative multiple reference tissue method for estimating pharmacokinetic parameters on prostate DCE MRI

Shoshana B. Ginsburg, B. Nicolas Bloch, Neil M. Rofsky, Elizabeth M. Genega, Robert E. Lenkinski, Anant Madabhushi

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Pharmacokinetic (PK) parameters are probes of tissue status that can be assessed by analysis of dynamic contrast-enhanced (DCE) MRI and are useful for prostate cancer (CaP) detection and grading. Traditionally, PK analysis requires knowledge of the time-resolved concentration of the contrast agent in the blood plasma, the arterial input function (AIF), which is typically estimated in an artery in the field-of-view (FOV). In cases when no suitable artery is present in the FOV, the multiple reference tissue method (MRTM) enables the estimation of PK parameters without the AIF by leveraging PK parameter values from the literature for a reference tissue in the FOV. Nevertheless, PK parameters estimated in the prostate vary significantly between patients. Consequently, population-based values obtained from the literature may introduce error into PK parameter estimation via MRTM. The objectives of this paper are two-fold. First we present a novel scheme, iterative MRTM (IMRTM), to estimate PK parameter values in the absence of the AIF without making assumptions about the PK constants associated with a reference tissue. Then, using IMRTM we investigate differences in PK constants between CaP in the peripheral zone (PZ) and CaP in the central gland (CG), as CG and PZ CaP have previously been shown to fidier significantly in terms of both texture and prognosis. We apply IMRTM to 15 patients with CaP in either the CG or the PZ who were scheduled for a radical prostatectomy and a pre-operative MRI. Values for the PK parameters K trans and νe estimated via IMRTM average 0.29 and 0.60 for normal central gland (CG), 0.29 and 0.64 for normal peripheral zone (PZ), and 0.30 and 0.53 for CaP. It is noteworthy that PK constants estimated in PZ CaP are significantly higher than those estimated in CG CaP (p ≤ 0.05). While both MRTM and IMRTM provide PK parameter values that are biologically feasible, IMRTM has the advantage that it invokes patient-specific information rather than relying on population-based PK constants in performing PK analysis.

Original languageEnglish (US)
Title of host publicationProceedings of SPIE - The International Society for Optical Engineering
Volume8670
DOIs
StatePublished - 2013
EventMedical Imaging 2013: Computer-Aided Diagnosis - Lake Buena Vista, FL, United States
Duration: Feb 12 2013Feb 14 2013

Other

OtherMedical Imaging 2013: Computer-Aided Diagnosis
CountryUnited States
CityLake Buena Vista, FL
Period2/12/132/14/13

Fingerprint

Pharmacokinetics
Magnetic resonance imaging
estimating
glands
Tissue
field of view
arteries
Field of View
blood plasma
Arteries
prognosis
textures
cancer
Prostate Cancer
Prognosis
Grading
Iterative Scheme
probes
Parameter estimation
Contrast Media

Keywords

  • Computer-aided diagnosis
  • DCE MRI
  • Pharmacokinetics
  • Prostate cancer
  • Reference region model

ASJC Scopus subject areas

  • Applied Mathematics
  • Computer Science Applications
  • Electrical and Electronic Engineering
  • Electronic, Optical and Magnetic Materials
  • Condensed Matter Physics

Cite this

Ginsburg, S. B., Bloch, B. N., Rofsky, N. M., Genega, E. M., Lenkinski, R. E., & Madabhushi, A. (2013). Iterative multiple reference tissue method for estimating pharmacokinetic parameters on prostate DCE MRI. In Proceedings of SPIE - The International Society for Optical Engineering (Vol. 8670). [86701J] https://doi.org/10.1117/12.2007715

Iterative multiple reference tissue method for estimating pharmacokinetic parameters on prostate DCE MRI. / Ginsburg, Shoshana B.; Bloch, B. Nicolas; Rofsky, Neil M.; Genega, Elizabeth M.; Lenkinski, Robert E.; Madabhushi, Anant.

Proceedings of SPIE - The International Society for Optical Engineering. Vol. 8670 2013. 86701J.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Ginsburg, SB, Bloch, BN, Rofsky, NM, Genega, EM, Lenkinski, RE & Madabhushi, A 2013, Iterative multiple reference tissue method for estimating pharmacokinetic parameters on prostate DCE MRI. in Proceedings of SPIE - The International Society for Optical Engineering. vol. 8670, 86701J, Medical Imaging 2013: Computer-Aided Diagnosis, Lake Buena Vista, FL, United States, 2/12/13. https://doi.org/10.1117/12.2007715
Ginsburg SB, Bloch BN, Rofsky NM, Genega EM, Lenkinski RE, Madabhushi A. Iterative multiple reference tissue method for estimating pharmacokinetic parameters on prostate DCE MRI. In Proceedings of SPIE - The International Society for Optical Engineering. Vol. 8670. 2013. 86701J https://doi.org/10.1117/12.2007715
Ginsburg, Shoshana B. ; Bloch, B. Nicolas ; Rofsky, Neil M. ; Genega, Elizabeth M. ; Lenkinski, Robert E. ; Madabhushi, Anant. / Iterative multiple reference tissue method for estimating pharmacokinetic parameters on prostate DCE MRI. Proceedings of SPIE - The International Society for Optical Engineering. Vol. 8670 2013.
@inproceedings{40906e6d59ac4f259a3522fc0d27f457,
title = "Iterative multiple reference tissue method for estimating pharmacokinetic parameters on prostate DCE MRI",
abstract = "Pharmacokinetic (PK) parameters are probes of tissue status that can be assessed by analysis of dynamic contrast-enhanced (DCE) MRI and are useful for prostate cancer (CaP) detection and grading. Traditionally, PK analysis requires knowledge of the time-resolved concentration of the contrast agent in the blood plasma, the arterial input function (AIF), which is typically estimated in an artery in the field-of-view (FOV). In cases when no suitable artery is present in the FOV, the multiple reference tissue method (MRTM) enables the estimation of PK parameters without the AIF by leveraging PK parameter values from the literature for a reference tissue in the FOV. Nevertheless, PK parameters estimated in the prostate vary significantly between patients. Consequently, population-based values obtained from the literature may introduce error into PK parameter estimation via MRTM. The objectives of this paper are two-fold. First we present a novel scheme, iterative MRTM (IMRTM), to estimate PK parameter values in the absence of the AIF without making assumptions about the PK constants associated with a reference tissue. Then, using IMRTM we investigate differences in PK constants between CaP in the peripheral zone (PZ) and CaP in the central gland (CG), as CG and PZ CaP have previously been shown to fidier significantly in terms of both texture and prognosis. We apply IMRTM to 15 patients with CaP in either the CG or the PZ who were scheduled for a radical prostatectomy and a pre-operative MRI. Values for the PK parameters K trans and νe estimated via IMRTM average 0.29 and 0.60 for normal central gland (CG), 0.29 and 0.64 for normal peripheral zone (PZ), and 0.30 and 0.53 for CaP. It is noteworthy that PK constants estimated in PZ CaP are significantly higher than those estimated in CG CaP (p ≤ 0.05). While both MRTM and IMRTM provide PK parameter values that are biologically feasible, IMRTM has the advantage that it invokes patient-specific information rather than relying on population-based PK constants in performing PK analysis.",
keywords = "Computer-aided diagnosis, DCE MRI, Pharmacokinetics, Prostate cancer, Reference region model",
author = "Ginsburg, {Shoshana B.} and Bloch, {B. Nicolas} and Rofsky, {Neil M.} and Genega, {Elizabeth M.} and Lenkinski, {Robert E.} and Anant Madabhushi",
year = "2013",
doi = "10.1117/12.2007715",
language = "English (US)",
isbn = "9780819494443",
volume = "8670",
booktitle = "Proceedings of SPIE - The International Society for Optical Engineering",

}

TY - GEN

T1 - Iterative multiple reference tissue method for estimating pharmacokinetic parameters on prostate DCE MRI

AU - Ginsburg, Shoshana B.

AU - Bloch, B. Nicolas

AU - Rofsky, Neil M.

AU - Genega, Elizabeth M.

AU - Lenkinski, Robert E.

AU - Madabhushi, Anant

PY - 2013

Y1 - 2013

N2 - Pharmacokinetic (PK) parameters are probes of tissue status that can be assessed by analysis of dynamic contrast-enhanced (DCE) MRI and are useful for prostate cancer (CaP) detection and grading. Traditionally, PK analysis requires knowledge of the time-resolved concentration of the contrast agent in the blood plasma, the arterial input function (AIF), which is typically estimated in an artery in the field-of-view (FOV). In cases when no suitable artery is present in the FOV, the multiple reference tissue method (MRTM) enables the estimation of PK parameters without the AIF by leveraging PK parameter values from the literature for a reference tissue in the FOV. Nevertheless, PK parameters estimated in the prostate vary significantly between patients. Consequently, population-based values obtained from the literature may introduce error into PK parameter estimation via MRTM. The objectives of this paper are two-fold. First we present a novel scheme, iterative MRTM (IMRTM), to estimate PK parameter values in the absence of the AIF without making assumptions about the PK constants associated with a reference tissue. Then, using IMRTM we investigate differences in PK constants between CaP in the peripheral zone (PZ) and CaP in the central gland (CG), as CG and PZ CaP have previously been shown to fidier significantly in terms of both texture and prognosis. We apply IMRTM to 15 patients with CaP in either the CG or the PZ who were scheduled for a radical prostatectomy and a pre-operative MRI. Values for the PK parameters K trans and νe estimated via IMRTM average 0.29 and 0.60 for normal central gland (CG), 0.29 and 0.64 for normal peripheral zone (PZ), and 0.30 and 0.53 for CaP. It is noteworthy that PK constants estimated in PZ CaP are significantly higher than those estimated in CG CaP (p ≤ 0.05). While both MRTM and IMRTM provide PK parameter values that are biologically feasible, IMRTM has the advantage that it invokes patient-specific information rather than relying on population-based PK constants in performing PK analysis.

AB - Pharmacokinetic (PK) parameters are probes of tissue status that can be assessed by analysis of dynamic contrast-enhanced (DCE) MRI and are useful for prostate cancer (CaP) detection and grading. Traditionally, PK analysis requires knowledge of the time-resolved concentration of the contrast agent in the blood plasma, the arterial input function (AIF), which is typically estimated in an artery in the field-of-view (FOV). In cases when no suitable artery is present in the FOV, the multiple reference tissue method (MRTM) enables the estimation of PK parameters without the AIF by leveraging PK parameter values from the literature for a reference tissue in the FOV. Nevertheless, PK parameters estimated in the prostate vary significantly between patients. Consequently, population-based values obtained from the literature may introduce error into PK parameter estimation via MRTM. The objectives of this paper are two-fold. First we present a novel scheme, iterative MRTM (IMRTM), to estimate PK parameter values in the absence of the AIF without making assumptions about the PK constants associated with a reference tissue. Then, using IMRTM we investigate differences in PK constants between CaP in the peripheral zone (PZ) and CaP in the central gland (CG), as CG and PZ CaP have previously been shown to fidier significantly in terms of both texture and prognosis. We apply IMRTM to 15 patients with CaP in either the CG or the PZ who were scheduled for a radical prostatectomy and a pre-operative MRI. Values for the PK parameters K trans and νe estimated via IMRTM average 0.29 and 0.60 for normal central gland (CG), 0.29 and 0.64 for normal peripheral zone (PZ), and 0.30 and 0.53 for CaP. It is noteworthy that PK constants estimated in PZ CaP are significantly higher than those estimated in CG CaP (p ≤ 0.05). While both MRTM and IMRTM provide PK parameter values that are biologically feasible, IMRTM has the advantage that it invokes patient-specific information rather than relying on population-based PK constants in performing PK analysis.

KW - Computer-aided diagnosis

KW - DCE MRI

KW - Pharmacokinetics

KW - Prostate cancer

KW - Reference region model

UR - http://www.scopus.com/inward/record.url?scp=84878398029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878398029&partnerID=8YFLogxK

U2 - 10.1117/12.2007715

DO - 10.1117/12.2007715

M3 - Conference contribution

AN - SCOPUS:84878398029

SN - 9780819494443

VL - 8670

BT - Proceedings of SPIE - The International Society for Optical Engineering

ER -